NeMusangano weGore negore wechi32 weUrology Association (CUA) wava kuda kuitirwa muDalian, ndiri kutanga patsva, ndichidzokorora ruzivo rwangu rwekare rweurological endoscopy. Mumakore angu ese e endoscopy, handisati ndamboona dhipatimendi rimwe chete richipa mhando dzakasiyana-siyana dze endoscopes, kusanganisira optical, electronic, uye zvakasiyana-siyana. Uyezve, urological endoscopes dziri kuchinja nekukurumidza, uye munyika, dzinopiwa mazita akasimba akadai se "cannonscope" uye "aircraft carrier scope." Chiitiko changu chekutanga nazvo chaishamisa. Ndakambonyora runyorwa rwezvitarisiko uye mhando dzeendoscopes dzinochinjika uye dzakasimba, izvo zvinoshanda sechiitiko chinokosha chekudzidza kubasa rangu.
Munguva pfupi yapfuura, ndanga ndichidzidza urological endoscopy ndisina pfungwa dzakanangana neizvi. Ndichainyora zvichienderana nenzvimbo yechirwere. Ndisati ndadzidza, ndichatanga ndanzwisisa ruzivo rwekutanga.
Ruzivo uye huwandu hwekuvhiyiwa hunodiwa kune mamwe mamiriro eurological
Urology ikozvino yakakamurwa kuita nzira yepamusoro yeweti (itsvo neureters), nzira yepasi yeweti (dundira neprostate), uye andrology. Uyezve, nehuwandu hwevanhu vari kukwegura, huwandu hwezvirwere zveweti hunotarisirwa kuwedzera. Data source: Chidzidzo chakaburitswa muScientific Reports neUrology Team yeFirst Affiliated Hospital yeSoochow University chakaita ongororo yekutanga yakazara yemutoro wepasi rose weBPH (benign prostatic hyperplasia) kubva muna 1990 kusvika 2021 zvichibva pane database yeGBD 2021. Ongororo yekuora kwemuviri yakasimbisa kuti 61% yekuwedzera kwezviitiko pasi rose kwakakonzerwa nekukwegura kwevanhu, 29% nekukura kwevanhu, uye 10% nekuchinja kwezvirwere.
Pakupera kwegore ra2024, huwandu hwevanhu vekuChina vane makore makumi matanhatu zvichikwira hwasvika mamiriyoni mazana matatu negumi nerimwe (anenge mamiriyoni mazana matatu negumi), zvichireva 22.0% yevanhu vose; pakati pavo, huwandu hwevanhu vane makore makumi matanhatu nemashanu zvichikwira hwasvika mamiriyoni mazana maviri nemakumi maviri nematatu (anenge mamiriyoni mazana maviri nemakumi maviri), zvichireva 15.6% yevanhu vose.
Kenza yeprostate (CA): Yakaiswa panzvimbo yekutanga pakati pekenza yemudumbu, nehuwandu hwekuwanda kwayo hunosvika 13.42 pavanhu 100,000. Zvichibva muguta rine vanhu vanosvika mamiriyoni mashanu, kune vanhu vatsva vanosvika 671 pagore. Zvichienderana neongororo ya2025 inonzi “Prostate Cancer Epidemiological Trends, Genomic Characteristics, and Future Directions for Optimized Management in China,” vanenge 54% yevarwere munyika yangu vane metastases dziri kure pakutanga kwekuongororwa. Nokudaro, huwandu hwevarwere vane zviratidzo zvekuvhiyiwa hunosvika 671 * 0.46 = 308.
Gomarara redundira: Huwandu hwevanhu vanobatwa negomarara iri i9.29 pavanhu 100,000, nehuwandu hwevanhu vatsva vanobatwa negomarara iri pagore hunosvika 465 muguta rine vanhu vanosvika mamiriyoni mashanu. Zvichibva padata repaindaneti, tichifunga kuti huwandu hwe75% hweNMIBC (Tis, Ta, T1) hunosvika 348, huwandu hwevanhu vatsva vanobatwa negomarara iri pagore hunosvika 348. Gomarara reitsvo reLaparoscopic: Huwandu hwevanhu vanobatwa negomarara iri i7.37 pavanhu 100,000, nehuwandu hwevanhu vatsva vanobatwa negomarara iri pagore hunosvika 368 muguta rine vanhu vanosvika mamiriyoni mashanu. Zvichibva pahunhu hwezvirwere zve "Ten-Year Study on Correlation between Surgical Trends and Clinicopathological Characteristics of Renal Cell Carcinoma" yakaburitswa nePeking University First Hospital, pT1 stage inokwana 79.6%, zvichikonzera kuti kuvhiyiwa kunofungidzirwa kuti kunosvika 293. Laparoscopic benign prostatic hyperplasia (BPH): Zvichibva padata riri pamusoro apa, panosvika 2024, pachava nevanhu mamiriyoni 310.31 munyika yangu vane makore makumi matanhatu zvichikwira, zvichireva 22.03% yevanhu, avo vanenge 48.73% vari varume (uyai varume, hamuchararami kwenguva yakareba sevakadzi). Kuwanda kweBPH kune avo vane makore makumi matanhatu zvichikwira i50%, uye 10% yavo inoda kuvhiyiwa. Huwandu hwevanhu vanoda kurapwa neBPH muguta rine vanhu vanosvika mamiriyoni mashanu ndehwekuti: mamiriyoni mashanu * 22.03% * 48.73% * 50% * 10% ≈ vanhu 26,838, zvinova zvakawanda kwazvo.
Matombo emuweti: Hapana ruzivo rwepamutemo rwuripo. Zvichienderana nehuwandu hwe5% hwezvirwere, 25% inoda kurapwa kwekuvhiyiwa. Muguta rine vanhu vanosvika mamiriyoni mashanu, huwandu hwezvirwere zvepagore uye kurapwa kunosvika 62,500, izvo zvakawandisa. Ehe, iyi ndiyo muganhu wepamusoro. Extracorporeal lithotripsy, ureteroscopic laser lithotripsy, uye percutaneous nephrolithotomy nepneumatic (laser) lithotripsy zvinoshandiswa.
Kubva kumusoro kusvika pasi zvichienderana nenzvimbo yemuviri
Percutaneous nephrolithotomy
Percutaneous nephrolithotomy (PCNL) inzira isinganyanyi kupindira inogadzira nzira inopinda nepaganda yekurapa matombo eitsvo kana maronda. Inonyanya kushandiswa kurapa matombo makuru (>2 cm) kana akaomarara eitsvo. Zvakanakira zvayo zvikuru zviri mukukuvara kushoma, kupora nekukurumidza, uye mwero wekubvisa matombo akawanda. Nephroscopes iri kuramba ichiwedzera kuva diki mudhayamita, ine nzira dzakajairwa (24-30 Fr), nzira diki (16-22 Fr), uye nzira dzakapfava (<16 Fr). Zvishandiso zve lithotripsy zvakaita setsono zvine dhayamita inosvika 1.4 mm zvava kuwanikwawo. Percutaneous nephrolithotomy michina yakajairika munzvimbo dzeutrological lithotripsy.
Nephroscope yepercutaneous ine nzvimbo yekuona ye12°, sheath ine elliptical, dhayamita yekunze ye8.5 Fr/12 Fr, kureba kwekushanda kunoshanda kweinenge 250 mm, uye mugero wekushanda weinenge 6 Fr.
Isu, Jiangxi Zhuoruihua Medical Instrument Co.,Ltd., tinogadzira zvinhu muChina zvine chekuita ne endoscopic consumables, zvinosanganisira GI line dzakadai se biopsy forceps, hemoclip, polyp snare, sclerotherapy needle, spray catheter, cytology brushes, guidewire wire, stone retrieval basket, nasal biliary drainage catheter nezvimwewo, izvo zvinoshandiswa zvakanyanya mu EMR, ESD, ERCP. Uye Urology Line, dzakadai sesheya yekupinda muureti ine kusvetauyesheya yekupinda muureti,Bhasikiti reKutora Matombo reWeti rinoraswauyenhungamiro yeurologynezvimwewo.
Zvigadzirwa zvedu zvakanyoreswa neCE, uye mafekitori edu akanyoreswa neISO. Zvinhu zvedu zvakatumirwa kuEurope, North America, Middle East nedzimwe nzvimbo dzeAsia, uye zviri kuita kuti mutengi azivikanwe uye arumbidzwe zvikuru!
Nguva yekutumira: Gunyana-22-2025